Evidence map›Paper›PMID 26316898›Full record

ArticleCancer nanotechnology

Size-dependent cellular toxicity and uptake of commercial colloidal gold nanoparticles in DU-145 cells.

Pallavi Vedantam, George Huang, T R Jeremy Tzeng

Abstract read
In one paragraph

Article in Cancer nanotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pallavi VedantamDepartment of Biological Sciences, Clemson University, Clemson, SC 29634 USA.
George HuangDepartment of Biological Sciences, Clemson University, Clemson, SC 29634 USA.
T R Jeremy TzengDepartment of Biological Sciences, Clemson University, Clemson, SC 29634 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary tract infection (UTI) is a predominant condition in prostate cancer patients.

Indexed as

BiodiagnosticCell uptakeCytotoxicityDU-145 cellsE. coliGold nanoparticlesMannoseProtein coronaUrinary tract infection

Identifiers

PMID26316898
PMCPMC4544071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.